Could a simple nose test uncover a missed lung condition?
NCT ID NCT07566611
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study aims to find out how often primary ciliary dyskinesia (PCD) goes undiagnosed in adults with bronchiectasis. Researchers will use two non-invasive tests—nasal nitric oxide measurement and high-speed video microscopy of nasal cells—to screen 60 participants. The goal is to improve detection of this genetic condition, which can cause chronic lung problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC BRONCHIECTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this screening approach could help doctors identify hidden cases of primary ciliary dyskinesia in adults with bronchiectasis, leading to more targeted care.
What could go wrong
This is a small, early-stage diagnostic study (60 participants) that has not yet started recruiting. The screening methods may not prove accurate enough for widespread use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.